Investing Profile

Tim Shannon

VCInvestor

General Partner at Canaan Partners

Your Intro Paths to Tim Shannon

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Tim Shannon on

Current Investing Position

Canaan Partners General Partner

Investment Range

$250K - $20.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$800M

Tim Shannon is on these Sector & Stage Rankings

Tim Shannon's Investments On Record (14)

Company	StageDateRound Size	Total Raised
Vivace Therapeutics	Series DMar 2025$35M Series CDec 2020$30M Series BJun 2017$25M Series AJan 2015$15M	$110M
Co-investors: Jake Simson (RA Capital)
Normunity	Series BJan 2025$75M Series AOct 2022$65M	$140M
Co-investors: Paulina Hill (Polaris Partners), Sakae Asanuma (Taiho Ventures), Sara Nayeem (Avoro Ventures)
Halda Therapeutics	Series BAug 2024$130M Series BDec 2021$51M Series AFeb 2019$25M	$200M
Co-investors: Arjun Goyal (Vida Ventures)
Acesion Pharma	Series BSep 2023$48M	$51M
Co-investors: Christopher de Souza (Broadview Ventures)
Aer Therapeutics	Series AApr 2023$36M	$36M
Co-investors: Rishi Gupta (OrbiMed), Christy Shaffer (Hatteras Venture Partners)
Rallybio	Series BApr 2020$150M Series AApr 2018$37M	$180M
Co-investors: Rob Hopfner (Pivotal bioVenture Partners)
NextCure	Series BNov 2018$93M Series AJan 2016$67M	$160M
Co-investors: Colleen Cuffaro (Canaan Partners), David Kabakoff (HealthQuest Capital)
Arvinas	Series CApr 2018$55M Series BOct 2015$42M Series ASep 2013$15M	$140M
Co-investors: Kush Parmar (5am Ventures), Colleen Cuffaro (Canaan Partners), Stephen Squinto (OrbiMed), Daniel Wagner (Connecticut Innovations), Liam Ratcliffe (Access Biotechnology), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest), Martin Alexander Gershon (Endeavor Venture Funds)